FDA Inspection 1100291 — ICE SpA
The FDA completed an inspection of ICE SpA on Nov 8, 2018 in Basaluzzo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 8, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Basaluzzo (Italy)
Additional details
Mutual Recognition Agreement (MRA)